Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Knowing when to use financial planning services can significantly impact your financial health. Discover the right timing for assistance.
24,264 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
XRP’s weekly RSI dipped below 30 for the second time in its trading history, reviving talk of a possible bounce after...
Oklo has zigzagged from a peak near $193 to much lower levels, raising questions about its momentum and prospects. Th...
When a prominent hedge fund reports selling a large block of shares, it sparks questions about the stock’s future. Th...
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
When a stimulus move hits a niche chip maker like Tower Semiconductor, investors ask what really caused it. This arti...
A sharp 36% February drop put Lemonade in the spotlight. This guide breaks down what happened, how the AI-driven grow...
What if the Oracle of Omaha retired having not purchased his beloved stock after decades of bets? This article dives ...
Kraken confirms the listing of Pi Network’s PI token, with trading starting March 13, 2026. The move underscores grow...
Start your week with a curated set of monday reads that translate headlines into practical investing moves. This guid...
A major fund just walked away from its Li Auto position, selling roughly $33 million worth of shares in one quarter. ...
AI is advancing beyond chips. NVIDIA's networking revenue just signals a broader shift to end-to-end AI infrastructur...